Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Ruxolitinib
Locations
7
South Korea
Busan University Hospital
Busan, South Korea
Dong-A University
Busan, South Korea
Kosin University Gospel Hospital
Busan, South Korea
Asan Medical Center
Seoul, South Korea
Korean Cancer Center Hospital
Seoul, South Korea
Chung-Ang University Hospital
Seoul, South Korea
Start Date
November 15, 2013
Primary Completion Date
June 30, 2017
Completion Date
September 18, 2018
Last Updated
November 1, 2018
NCT06026319
NCT03625037
NCT05507541
NCT04875195
NCT01897571
NCT05733650
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions